In Brief: Glades Pharmaceuticals
This article was originally published in The Tan Sheet
Executive Summary
Glades Pharmaceuticals: Stiefel subsidiary introduces five-SKU line of capsaicin products, which the firm calls the "first and only generic purified capsaicin." Glades claims in a Jan. 3 release that the purified capsaicin is unlike the oleoresin form of capsaicin used in GenDerm's Zostrix topical analgesics. GenDerm filed a patent infringement lawsuit against Stiefel in October, seeking to bar the firm from infringing its Zostrix patent by selling capsaicin products ("The Tan Sheet" Nov. 21, 1994, In Brief)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning